Total Debt Summary of MedMira Inc.

MedMira Inc.'s latest annual total debt in 2023 was 9.27 Million CAD , up 11.71% from previous year.
MedMira Inc.'s latest quarterly total debt in 2024 Q3 was 8.85 Million CAD , down -0.85% from previous quarter.
MedMira Inc. reported annual total debt of 8.29 Million CAD in 2022, down -28.06% from previous year.
MedMira Inc. reported annual total debt of 11.53 Million CAD in 2021, down -3.15% from previous year.
MedMira Inc. reported quarterly total debt of 9.25 Million CAD for 2024 Q1, down -0.14% from previous quarter.
MedMira Inc. reported quarterly total debt of 8.85 Million CAD for 2024 Q3, down -0.85% from previous quarter.

Annual Total Debt Chart of MedMira Inc. (2023 - 2000)

Historical Annual Total Debt of MedMira Inc. (2023 - 2000)

Year	Total Debt	Total Debt Growth
2023	9.27 Million CAD	11.71%
2022	8.29 Million CAD	-28.06%
2021	11.53 Million CAD	-3.15%
2020	11.91 Million CAD	38.33%
2019	8.61 Million CAD	13.54%
2018	7.58 Million CAD	9.29%
2017	6.93 Million CAD	11.04%
2016	6.24 Million CAD	-10.15%
2015	6.95 Million CAD	11.81%
2014	6.22 Million CAD	-9.5%
2013	6.87 Million CAD	-7.26%
2012	7.41 Million CAD	-49.41%
2011	14.65 Million CAD	14.89%
2010	12.75 Million CAD	8.79%
2009	11.72 Million CAD	9.44%
2008	10.71 Million CAD	4.74%
2007	10.22 Million CAD	8.41%
2006	9.43 Million CAD	15.5%
2005	8.16 Million CAD	76.27%
2004	4.63 Million CAD	141.02%
2003	1.92 Million CAD	-79.73%
2002	9.48 Million CAD	25205.64%
2001	37.49 Thousand CAD	-99.38%
2000	6.03 Million CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	8.92 Million CAD	-3.59%
2024 Q1	9.25 Million CAD	-0.14%
2024 Q3	8.85 Million CAD	-0.85%
2023 Q2	8.88 Million CAD	2.96%
2023 FY	9.27 Million CAD	11.71%
2023 Q1	8.62 Million CAD	3.97%
2023 Q4	9.27 Million CAD	-0.54%
2023 Q3	9.32 Million CAD	4.93%
2022 Q2	8.39 Million CAD	-26.97%
2022 Q4	8.29 Million CAD	-0.65%
2022 Q1	11.5 Million CAD	-0.29%
2022 FY	8.29 Million CAD	-28.06%
2022 Q3	8.35 Million CAD	-0.55%
2021 Q1	11.82 Million CAD	-0.68%
2021 Q2	11.72 Million CAD	-0.84%
2021 FY	11.53 Million CAD	-3.15%
2021 Q3	11.51 Million CAD	-1.85%
2021 Q4	11.53 Million CAD	0.2%
2020 Q1	11.28 Million CAD	31.05%
2020 Q2	11.82 Million CAD	4.76%
2020 Q3	11.95 Million CAD	1.18%
2020 Q4	11.91 Million CAD	-0.41%
2020 FY	11.91 Million CAD	38.33%
2019 FY	8.61 Million CAD	13.54%
2019 Q4	8.61 Million CAD	4.37%
2019 Q3	8.24 Million CAD	0.62%
2019 Q2	8.19 Million CAD	2.75%
2019 Q1	7.97 Million CAD	5.22%
2018 Q4	7.58 Million CAD	0.59%
2018 FY	7.58 Million CAD	9.29%
2018 Q1	7.31 Million CAD	5.48%
2018 Q2	7.41 Million CAD	1.26%
2018 Q3	7.53 Million CAD	1.73%
2017 Q4	6.93 Million CAD	4.48%
2017 Q2	6.24 Million CAD	-0.29%
2017 Q1	6.26 Million CAD	0.21%
2017 Q3	6.64 Million CAD	6.36%
2017 FY	6.93 Million CAD	11.04%
2016 Q4	6.24 Million CAD	4.65%
2016 FY	6.24 Million CAD	-10.15%
2016 Q3	5.97 Million CAD	-2.89%
2016 Q2	6.14 Million CAD	-4.76%
2016 Q1	6.45 Million CAD	-7.17%
2015 FY	6.95 Million CAD	11.81%
2015 Q3	6.17 Million CAD	-6.85%
2015 Q4	6.95 Million CAD	12.59%
2015 Q1	6.4 Million CAD	3.04%
2015 Q2	6.63 Million CAD	3.47%
2014 Q4	6.22 Million CAD	7.59%
2014 Q1	6.33 Million CAD	-7.86%
2014 FY	6.22 Million CAD	-9.5%
2014 Q2	6.11 Million CAD	-3.45%
2014 Q3	5.78 Million CAD	-5.45%
2013 Q3	6.29 Million CAD	3.71%
2013 Q1	7.81 Million CAD	5.44%
2013 FY	6.87 Million CAD	-7.26%
2013 Q4	6.87 Million CAD	9.28%
2013 Q2	6.06 Million CAD	-22.4%
2012 Q1	14.5 Million CAD	-0.99%
2012 Q3	17.01 Million CAD	-0.48%
2012 FY	7.41 Million CAD	-49.41%
2012 Q4	7.41 Million CAD	-56.44%
2012 Q2	17.1 Million CAD	17.86%
2011 Q2	14.56 Million CAD	9.25%
2011 Q1	13.32 Million CAD	4.51%
2011 Q3	14.71 Million CAD	1.05%
2011 Q4	14.65 Million CAD	-0.42%
2011 FY	14.65 Million CAD	14.89%
2010 FY	12.75 Million CAD	8.79%
2010 Q1	6.81 Million CAD	-41.87%
2010 Q2	9.38 Million CAD	37.75%
2010 Q3	11.93 Million CAD	27.2%
2010 Q4	12.75 Million CAD	6.82%
2009 Q1	11.22 Million CAD	4.81%
2009 Q2	12.16 Million CAD	8.33%
2009 Q3	11.87 Million CAD	-2.4%
2009 Q4	11.72 Million CAD	-1.25%
2009 FY	11.72 Million CAD	9.44%
2008 Q1	9.74 Million CAD	-4.71%
2008 FY	10.71 Million CAD	4.74%
2008 Q4	10.71 Million CAD	7.05%
2008 Q3	10 Million CAD	-2.12%
2008 Q2	10.22 Million CAD	4.91%
2007 FY	10.22 Million CAD	8.41%
2007 Q1	21.84 Million CAD	131.49%
2007 Q3	10.56 Million CAD	0.06%
2007 Q4	10.22 Million CAD	-3.23%
2007 Q2	10.56 Million CAD	-51.64%
2006 FY	9.43 Million CAD	15.5%
2006 Q4	9.43 Million CAD	14.21%
2006 Q3	8.26 Million CAD	-25.86%
2006 Q1	10.59 Million CAD	29.71%
2006 Q2	11.14 Million CAD	5.16%
2005 Q4	8.16 Million CAD	15.86%
2005 FY	8.16 Million CAD	76.27%
2005 Q1	6.36 Million CAD	37.35%
2005 Q2	6.68 Million CAD	5.09%
2005 Q3	7.05 Million CAD	5.4%
2004 Q1	2 Million CAD	4.16%
2004 FY	4.63 Million CAD	141.02%
2004 Q3	3.42 Million CAD	49.49%
2004 Q4	4.63 Million CAD	35.35%
2004 Q2	2.29 Million CAD	14.36%
2003 Q3	9.51 Million CAD	4.79%
2003 Q1	9.53 Million CAD	0.54%
2003 FY	1.92 Million CAD	-79.73%
2003 Q2	9.07 Million CAD	-4.83%
2003 Q4	1.92 Million CAD	-79.79%
2002 Q3	1.4 Million CAD	81.55%
2002 FY	9.48 Million CAD	25205.64%
2002 Q2	773.4 Thousand CAD	142.33%
2002 Q4	9.48 Million CAD	575.68%
2002 Q1	319.15 Thousand CAD	0.0%
2001 FY	37.49 Thousand CAD	-99.38%
2000 FY	6.03 Million CAD	0.0%

Peer Total Debt Comparison of MedMira Inc.

Name	Total Debt	Total Debt Difference
Arch Biopartners Inc.	5.01 Million CAD	-84.826%
Covalon Technologies Ltd.	1.56 Million CAD	-493.37%
Hemostemix Inc.	4.32 Million CAD	-114.536%
Universal Ibogaine Inc.	1.73 Million CAD	-433.541%
Kane Biotech Inc.	8.27 Million CAD	-12.026%
Marvel Biosciences Corp.	1 Million CAD	-827.12%
NervGen Pharma Corp.	197.19 Thousand CAD	-4601.659%
XORTX Therapeutics Inc.	15.17 Thousand CAD	-60987.185%

Global Stocks Search

MedMira Inc. (MIR.V)

Total Debt Summary of MedMira Inc.

Annual Total Debt Chart of MedMira Inc. (2023 - 2000)

Historical Annual Total Debt of MedMira Inc. (2023 - 2000)

Peer Total Debt Comparison of MedMira Inc.